Open
3 CPD Points
Use of Pembrolizumab in Non-Small Cell Lung Cancer (NSCLC)
Start date
14-02-2024
End date
14-02-2024
Time
08:00 AM
Location
UCI-330
Cost
0
CPD points
3
About this activity
CME session providing updates in use of monoclonal antibodies in Lung Cancer